Highline Wealth Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Highline Wealth Partners’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.42K	Hold	98	–	–	﹤0.01%	1229
2026 Q1	$1.36K	Sell	98 -46	-32%	-$640	﹤0.01%	1122
2025 Q4	$2.02K	Hold	144	–	–	﹤0.01%	847
2025 Q3	$2.01K	Hold	144	–	–	﹤0.01%	848
2025 Q2	$2.16K	Sell	144 -20	-12%	-$286	﹤0.01%	627
2025 Q1	$2.16K	Sell	164 -26	-14%	-$359	﹤0.01%	613
2024 Q4	$3K	Sell	190 -45	-19%	-$676	﹤0.01%	413
2024 Q3	$3.73K	Buy	235 +45	+24%	+$724	﹤0.01%	381
2024 Q2	$2.9K	Buy	+190	New	+$2.72K	﹤0.01%	344

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Highline Wealth Partners's RDY Position: Q2 2026 in Review

Highline Wealth Partners held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 98 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1229.

Highline Wealth Partners first reported a position in RDY in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.73K in Q3 2024. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Highline Wealth Partners held 98 shares of Dr. Reddy's Laboratories worth $1.42K as of Q2 2026.
Highline Wealth Partners left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #1229 holding.
Highline Wealth Partners first reported a position in Dr. Reddy's Laboratories in Q2 2024 and has held it in 9 quarters since.
Highline Wealth Partners's Dr. Reddy's Laboratories position peaked at $3.73K in Q3 2024.
239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.